← Leaderboards
Meike Dittmann
Rockefeller University
$3,056,621
Attributed
$3,056,621
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $811.2K · FY2016–22$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,056,621 · 4
By mechanism
R01$2,033,932 · 1
R00$498,000 · 1
R21$466,125 · 1
K99$58,564 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Charles M. Rice$80,497,748
- John W. Schoggins$10,987,205
- Thomas Tuschl$29,870,416
- Timothy Patrick Sheahan$10,595,033
Others in their field
Top investigators on “Mortality”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$293,517,891
- Lawrence Corey · Fred Hutchinson Cancer Center$289,968,959
- Judith S. Currier · University Of California Los Angeles$286,517,393
- James Dennis Neaton · Northwestern University$278,695,034
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel R Kuritzkes · Brigham And Women'S Hospital$261,859,249
Research focus
MortalityInfluenza A VirusDrug DesignIntegration Host FactorsMediatingAdenovirusesVirusAntiviral AgentsVirus DiseasesViralInnovationInterferonsLeadAntiviral TherapyExperimental StudyInnate Immune SystemDrug TargetingPhysiologicalPara-Influenza Virus Type 3GenesIn VivoLungInhibitor/AntagonistImage
Grant awards (11)
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$478,548
R01 · FY2022 · AI · contact PI
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$487,446
R01 · FY2021 · AI · contact PI
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$34,200
R01 · FY2021 · AI · contact PI
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$433,545
R01 · FY2020 · AI · contact PI
SERPINs as a novel family of innate antiviral molecules - Resubmission - 1$211,875
R21 · FY2020 · AI · contact PI
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$165,800
R01 · FY2020 · AI · contact PI
ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity$434,393
R01 · FY2019 · AI · contact PI
SERPINs as a novel family of innate antiviral molecules - Resubmission - 1$254,250
R21 · FY2019 · AI · contact PI
Intrinsic and innate barriers to respiratory virus infections$249,000
R00 · FY2018 · AI · contact PI
Intrinsic and innate barriers to respiratory virus infections$249,000
R00 · FY2017 · AI · contact PI
Intrinsic and innate barriers to respiratory virus infections$58,564
K99 · FY2016 · AI · contact PI